These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Acid reduction in peptic ulcer disease. Choosing therapy according to drug interactions, individual response, and cost. Parent K Postgrad Med; 1994 Nov; 96(6):53-9. PubMed ID: 7971612 [TBL] [Abstract][Full Text] [Related]
44. [Helicobacter pylori, non-steroidal anti-inflammatory drugs and aspirin: a new piece of the puzzle]. Lesur G Gastroenterol Clin Biol; 2001; 25(6-7):725-6. PubMed ID: 11688500 [No Abstract] [Full Text] [Related]
45. Prevention and treatment of non-steroidal anti-inflammatory drug-induced gastro-duodenal damage: rationale for the use of antisecretory compounds. Scarpignato C; Pelosini I Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S63-72. PubMed ID: 10379472 [TBL] [Abstract][Full Text] [Related]
46. Is the steroid ulcer a myth? Spiro HM N Engl J Med; 1983 Jul; 309(1):45-7. PubMed ID: 6134237 [No Abstract] [Full Text] [Related]
47. Advances in the treatment of peptic ulcer disease. Camara DS Compr Ther; 1987 Aug; 13(8):13-6. PubMed ID: 2887333 [No Abstract] [Full Text] [Related]
48. Nonsteroidal antiinflammatory drugs and the gastrointestinal tract. Hirschowitz BI Gastroenterologist; 1994 Sep; 2(3):207-23. PubMed ID: 7987619 [TBL] [Abstract][Full Text] [Related]
49. [Peptic ulcer: changing indications for gastric resection during the last 15 years]. Della Beffa V; Carelli-Basile A; Leli R; Fontana D Minerva Chir; 1994 Nov; 49(11):1065-9. PubMed ID: 7708225 [TBL] [Abstract][Full Text] [Related]
51. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis. Goldstein JL; Huang B; Amer F; Christopoulos NG Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480 [TBL] [Abstract][Full Text] [Related]
52. Prevention of ulcer relapse: rationale. Dobrilla G Hepatogastroenterology; 1988 Dec; 35(6):295-9. PubMed ID: 2905690 [No Abstract] [Full Text] [Related]
53. [Long-term medical prophylaxis of peptic ulcer disease]. Rohner HG Dtsch Med Wochenschr; 1986 Jan; 111(3):117-8. PubMed ID: 2866944 [No Abstract] [Full Text] [Related]
54. [Pathophysiologic bases of the pharmacotherapy of peptic ulcer]. Grigor'ev PIa; Isakov VA; Vasil'eva ZI Klin Med (Mosk); 1988 Nov; 66(11):19-27. PubMed ID: 2907071 [No Abstract] [Full Text] [Related]
55. Use of gastroprotective drugs in patients receiving low-dose aspirin. Luk HH J Chin Med Assoc; 2009 Jul; 72(7):356-61. PubMed ID: 19581141 [TBL] [Abstract][Full Text] [Related]
56. [Acetylsalicylic acid in arterial circulatory disorders. Which dosage in which indication?]. Ranke C; Creutzig A; Alexander K Dtsch Med Wochenschr; 1994 Jun; 119(22):815-21. PubMed ID: 8205945 [No Abstract] [Full Text] [Related]
57. Mandate to modify a medicinal mantra: maybe not yet? Peura DA Gastroenterology; 2003 Mar; 124(3):842-4. PubMed ID: 12612918 [No Abstract] [Full Text] [Related]
58. Do we need stress ulcer prophylaxis? Reines HD Crit Care Med; 1990 Mar; 18(3):344. PubMed ID: 1968001 [No Abstract] [Full Text] [Related]
59. Endoscopic ulcers with low-dose aspirin and reality testing. Graham DY; Chan FK Gastroenterology; 2005 Mar; 128(3):807; author reply 807--8. PubMed ID: 15765433 [No Abstract] [Full Text] [Related]